Johan Neyts
Johan Neyts
Άγνωστη συνεργασία
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα
Παρατίθεται από
Παρατίθεται από
Angiogenesis: regulators and clinical applications
S Liekens, E De Clercq, J Neyts
Biochemical pharmacology 61 (3), 253-270, 2001
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts, L Vijgen, P Maes, J Neyts, M Van Ranst
Biochemical and biophysical research communications 323 (1), 264-268, 2004
Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture
AH De Wilde, D Jochmans, CC Posthuma, JC Zevenhoven-Dobbe, ...
Antimicrobial agents and chemotherapy 58 (8), 4875-4884, 2014
The non‐immunosuppressive cyclosporin DEBIO‐025 is a potent inhibitor of hepatitis C virus replication in vitro
J Paeshuyse, A Kaul, E De Clercq, B Rosenwirth, JM Dumont, P Scalfaro, ...
Hepatology 43 (4), 761-770, 2006
The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine) n-specific plant lectin from Urtica dioica are potent and …
J Balzarini, J Neyts, D Schols, M Hosoya, E Van Damme, W Peumans, ...
Antiviral research 18 (2), 191-207, 1992
An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge
G Yang, DC Pevear, MH Davies, MS Collett, T Bailey, S Rippen, L Barone, ...
Journal of virology 79 (20), 13139-13149, 2005
HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: a review of their pharmacology and clinical potential in the treatment of viral infections
L Naesens, R Snoeck, G Andrei, J Balzarini, J Neyts, E De Clercq
Antiviral Chemistry and Chemotherapy 8 (1), 1-23, 1997
Perspectives for the Treatment of Infections withFlaviviridae
P Leyssen, E De Clercq, J Neyts
Clinical microbiology reviews 13 (1), 67-82, 2000
Alpha-(1-3)-and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro.
J Balzarini, D Schols, J Neyts, E Van Damme, W Peumans, E De Clercq
Antimicrobial agents and chemotherapy 35 (3), 410-416, 1991
Structure and functionality in flavivirus NS-proteins: perspectives for drug design
M Bollati, K Alvarez, R Assenberg, C Baronti, B Canard, S Cook, ...
Antiviral research 87 (2), 125-148, 2010
The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase
P Leyssen, J Balzarini, E De Clercq, J Neyts
Journal of virology 79 (3), 1943-1947, 2005
Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties
P Proost, E Schutyser, P Menten, S Struyf, A Wuyts, G Opdenakker, ...
Blood, The Journal of the American Society of Hematology 98 (13), 3554-3561, 2001
Selective inhibitors of picornavirus replication
AM De Palma, I Vliegen, E De Clercq, J Neyts
Medicinal research reviews 28 (6), 823-884, 2008
Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug
E Mastrangelo, M Pezzullo, T De Burghgraeve, S Kaptein, B Pastorino, ...
Journal of Antimicrobial Chemotherapy 67 (8), 1884-1894, 2012
The Viral Polymerase Inhibitor 7-Deaza-2’-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust …
J Zmurko, RE Marques, D Schols, E Verbeken, SJF Kaptein, J Neyts
PLoS neglected tropical diseases 10 (5), e0004695, 2016
DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A
L Coelmont, X Hanoulle, U Chatterji, C Berger, J Snoeck, M Bobardt, ...
PloS one 5 (10), e13687, 2010
Synthesis of new benzimidazole–coumarin conjugates as anti-hepatitis C virus agents
JR Hwu, R Singha, SC Hong, YH Chang, AR Das, I Vliegen, E De Clercq, ...
Antiviral research 77 (2), 157-162, 2008
Antiviral drug susceptibility of human herpesvirus 8.
J Neyts, E De Clercq
Antimicrobial Agents and Chemotherapy 41 (12), 2754-2756, 1997
Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2
N Kolocouris, A Kolocouris, GB Foscolos, G Fytas, J Neyts, E Padalko, ...
Journal of medicinal chemistry 39 (17), 3307-3318, 1996
Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate
J Neyts, R Snoeck, D Schols, J Balzarini, JD Esko, A Van Schepdael, ...
Virology 189 (1), 48-58, 1992
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20